【揭秘首个国产新冠口服药:原本用于治疗艾滋病,每片售价25.86元】China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus.
Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients with high viral loads on July 20 last year, according to the National Medical Products Administration.
The newly issued greenlight, made possible via an emergency, accelerated approval process, clears the way for the pill to be used for adult COVID-19 patients with moderate symptoms, the administration said in a notice released on its official website.
According to the company, third and late-stage clinical trials show that the oral medication is safe, can improve clinical conditions of patients and inhibit the virus within about five days.
Chang Junbiao, vice president of Zhengzhou University and a leading researcher of the pill, said during an interview with Henan Daily that clinical trials show that the drug is effective against all emerging variants, including Omicron.
He said that the medication's price has not been determined, but should be much lower than pharmaceutical company Pfizer's Paxlovid pill, which costs about 2,300 yuan (US$340) per dose.
Azvudine cost 25.86 yuan/mg (pill) for HIV treatment. It is expected Azvudine's price for COVID-19 treatment will be similar.
(chinadaily.com.cn)
Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients with high viral loads on July 20 last year, according to the National Medical Products Administration.
The newly issued greenlight, made possible via an emergency, accelerated approval process, clears the way for the pill to be used for adult COVID-19 patients with moderate symptoms, the administration said in a notice released on its official website.
According to the company, third and late-stage clinical trials show that the oral medication is safe, can improve clinical conditions of patients and inhibit the virus within about five days.
Chang Junbiao, vice president of Zhengzhou University and a leading researcher of the pill, said during an interview with Henan Daily that clinical trials show that the drug is effective against all emerging variants, including Omicron.
He said that the medication's price has not been determined, but should be much lower than pharmaceutical company Pfizer's Paxlovid pill, which costs about 2,300 yuan (US$340) per dose.
Azvudine cost 25.86 yuan/mg (pill) for HIV treatment. It is expected Azvudine's price for COVID-19 treatment will be similar.
(chinadaily.com.cn)
好怀念五六年以前什么都有但我什么都不懂的时候,记得看一篇瓶邪的同人文,小哥在野外拿一个矿泉水瓶子里面怼根管子,要给吴邪guan 那个chang,我当时真的啥玩意儿不知道,还想怎么喝个水还要那么长一塑胶吸管,吴邪不能站起来喝吗?
迷迷瞪瞪看完了,快一年了我才反应过来他们在干啥,但现在我啥都懂了,但又什么都没得看了[苦涩]
迷迷瞪瞪看完了,快一年了我才反应过来他们在干啥,但现在我啥都懂了,但又什么都没得看了[苦涩]
#英雄联盟[超话]# #英雄联盟泳池派对#
-
LOL泳池派对cos团片 速报 ·
剑姬/女警/德莱文/拉克丝/佐伊/女枪
-
皮城女警·凯特琳:@Vv子教授
盲僧·李青:@放飞的Mr-Chang
无双剑姬·菲奥娜:@garlie咖喱嘉
赏金猎人·厄运小姐:@coser少少
光辉女郎·拉克丝:@锦玉joan
荣耀行刑官·德莱文:@江锦衣
暮光星灵·佐伊:@花狸抱猫
-
组织:@英雄联盟同人
摄影:@胖大珊
地址:康之泉星城活水馆
-
【海之歌】皮肤系列也是属于【泳池派对】皮肤宇宙中的!!QAQ
-
LOL泳池派对cos团片 速报 ·
剑姬/女警/德莱文/拉克丝/佐伊/女枪
-
皮城女警·凯特琳:@Vv子教授
盲僧·李青:@放飞的Mr-Chang
无双剑姬·菲奥娜:@garlie咖喱嘉
赏金猎人·厄运小姐:@coser少少
光辉女郎·拉克丝:@锦玉joan
荣耀行刑官·德莱文:@江锦衣
暮光星灵·佐伊:@花狸抱猫
-
组织:@英雄联盟同人
摄影:@胖大珊
地址:康之泉星城活水馆
-
【海之歌】皮肤系列也是属于【泳池派对】皮肤宇宙中的!!QAQ
✋热门推荐